ZCI
DGX icon

Zevenbergen Capital Investments’s Quest Diagnostics DGX Stock Holding History

Zevenbergen Capital Investments’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.4M Buy
11,315
+240
+2% +$47.1K 0.05% 84
2026
Q1 		$2.17M Buy
11,075
+655
+6% +$127K 0.06% 85
2025
Q4 		$1.81M Buy
10,420
+1,185
+13% +$216K 0.04% 88
2025
Q3 		$1.76M Buy
9,235
+5,185
+128% +$920K 0.03% 85
2025
Q2 		$728K Buy
+4,050
New +$703K 0.01% 92

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Zevenbergen Capital Investments's DGX Position: Q2 2026 in Review

Zevenbergen Capital Investments increased its Quest Diagnostics (DGX) stake by 2.2% in Q2 2026, buying an estimated $47.1K and bringing the position to 11,315 shares worth $2.4M. The position accounts for 0.05% of the portfolio, ranked #84.

Zevenbergen Capital Investments first reported a position in DGX in Q2 2025 and has held it in 5 quarters since. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Zevenbergen Capital Investments held 11,315 shares of Quest Diagnostics worth $2.4M as of Q2 2026.
  • Zevenbergen Capital Investments bought 240 Quest Diagnostics shares in Q2 2026, an estimated $47.1K.
  • Quest Diagnostics made up 0.05% of Zevenbergen Capital Investments's portfolio in Q2 2026, its #84 holding.
  • Zevenbergen Capital Investments first reported a position in Quest Diagnostics in Q2 2025 and has held it in 5 quarters since.
  • 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Zevenbergen Capital Investments's 13F filing for Q2 2026, filed 16 Jul 2026.